1. Home
  2. PLUR vs MBBC Comparison

PLUR vs MBBC Comparison

Compare PLUR & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$2.39

Market Cap

36.3M

Sector

Health Care

ML Signal

N/A

MBBC

Marathon Bancorp Inc.

N/A

Current Price

$14.02

Market Cap

40.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PLUR
MBBC
Founded
2001
1902
Country
Israel
United States
Employees
N/A
35
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
40.2M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
PLUR
MBBC
Price
$2.39
$14.02
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
15.0K
18.3K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
10.78
N/A
EPS
N/A
N/A
Revenue
$1,336,000.00
N/A
Revenue This Year
$97.38
N/A
Revenue Next Year
$293.97
N/A
P/E Ratio
N/A
$47.11
Revenue Growth
309.82
N/A
52 Week Low
$2.22
$9.95
52 Week High
$5.96
$15.75

Technical Indicators

Market Signals
Indicator
PLUR
MBBC
Relative Strength Index (RSI) 33.53 54.56
Support Level $2.22 $12.90
Resistance Level $2.60 $15.57
Average True Range (ATR) 0.19 0.54
MACD -0.02 0.02
Stochastic Oscillator 13.73 77.72

Price Performance

Historical Comparison
PLUR
MBBC

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

Share on Social Networks: